Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (Details)

v3.22.1
STOCKHOLDERS' EQUITY (Details)
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Weighted average remaining life, Exercisable 9 years 5 months 15 days
Common Stock Warrants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Class of Warrant or Right, Outstanding 5,174,209
Weighted average exercise price, outstanding | $ / shares $ 1.16
Granted 333,334
Weighted average exercise price, granted | $ / shares $ 3.75
Cancelled 0
Expired 0
Exercised (6,250)
Weighted average exercise price, exercised | $ / shares $ 0.004
Class of Warrant or Right, Outstanding 5,501,293
Weighted average exercise price, outstanding | $ / shares $ 1.31
Weighted average remaining life 8 years 6 months 10 days
Intrinsic Value, outstanding | $ $ 4,749,456
Exercisable 5,501,293
Weighted average exercise price, exercisable | $ / shares $ 1.31
Weighted average remaining life, Exercisable 8 years 6 months 10 days
Intrinsic Value, exercisable | $ $ 4,749,456